Combined sialic acid and histone deacetylase (HDAC) inhibitor treatment up-regulates the neuroblastoma antigen GD2
van den Bijgaart, Renske J.E., Kroesen, Michiel, Wassink, Melissa, Brok, Ingrid C., Kers-Rebel, Esther D., Boon, Louis, Heise, Torben, van Scherpenzeel, Monique, Lefeber, Dirk J., Boltje, Thomas J., den Brok, Martijn H., Hoogerbrugge, Peter M., Büll, Christian, Adema, Gosse J.
Published in The Journal of biological chemistry (22.03.2019)
Published in The Journal of biological chemistry (22.03.2019)
Get full text
Journal Article
Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model
van den Bijgaart, Renske J E, Kroesen, Michiel, Brok, Ingrid C, Reijnen, Daphne, Wassink, Melissa, Boon, Louis, Hoogerbrugge, Peter M, Adema, Gosse J
Published in Oncoimmunology (01.01.2020)
Published in Oncoimmunology (01.01.2020)
Get full text
Journal Article
HDAC inhibitors and immunotherapy; a double edged sword?
Kroesen, Michiel, Gielen, Paul, Brok, Ingrid C, Armandari, Inna, Hoogerbrugge, Peter M, Adema, Gosse J
Published in Oncotarget (30.08.2014)
Published in Oncotarget (30.08.2014)
Get full text
Journal Article
Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
Kroesen, Michiel, Büll, Christian, Gielen, Paul R., Brok, Ingrid C., Armandari, Inna, Wassink, Melissa, Looman, Maaike W. G., Boon, Louis, den Brok, Martijn H., Hoogerbrugge, Peter M., Adema, Gosse J.
Published in Oncoimmunology (02.06.2016)
Published in Oncoimmunology (02.06.2016)
Get full text
Journal Article
Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents
Kroesen, Michiel, Brok, Ingrid C., Reijnen, Daphne, van Hout-Kuijer, Maaike A., Zeelenberg, Ingrid S., Den Brok, Martijn H., Hoogerbrugge, Peter M., Adema, Gosse J.
Published in Cancer Immunology, Immunotherapy (01.05.2015)
Published in Cancer Immunology, Immunotherapy (01.05.2015)
Get full text
Journal Article
Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model
van den Bijgaart, Renske J. E., Kroesen, Michiel, Brok, Ingrid C., Reijnen, Daphne, Wassink, Melissa, Boon, Louis, Hoogerbrugge, Peter M., Adema, Gosse J
Published in OncoImmunology (01.01.2020)
Published in OncoImmunology (01.01.2020)
Get full text
Report